selected publications
-
academic article
- Expression of Programmed Death-Ligand 1 by Human Colonic CD90+ Stromal Cells Differs Between Ulcerative Colitis and Crohn's Disease and Determines Their Capacity to Suppress Th1 Cells.. Frontiers in immunology. 9:-. 2018
- Isolation of CD 90+ Fibroblast/Myofibroblasts from Human Frozen Gastrointestinal Specimens.. Journal of visualized experiments : JoVE. :-. 2016
- CD90(+) stromal cells are the major source of IL-6 which supports cancer stem-like cells and inflammation in colorectal cancer.. International journal of cancer. Journal international du cancer. :-. 2015
- TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.. Journal of immunology (Baltimore, Md. : 1950). 193:2218-2229. 2014
- TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells. Journal of Immunology. 193:2218-2229. 2014
- Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells.. Gastroenterology. 140:2019-2030. 2011
- PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity.. Gastroenterology. 135:1228-1237, 1237.e1-2. 2008